Advertising seems to be blocked by your browser.
The ads help us provide this software and web site to you for free.
Please support our project by allowing our site to show ads.
Driver Date |
2013-01-14 | |
Version |
1.2.722.0 | |
Driver for |
Windows 2000 (5.0) 32 bit Windows XP (5.1) 32 bit Windows Server 2003 (5.2) 32 bit Windows Vista (6.0) 32 bit Windows 7 (6.1) 32 bit Windows 8 (6.2) 32 bit Windows 8.1 (6.3) 32 bit Windows 10 (10.0) 32 bit |
Download |
Driver Date |
2013-01-14 | |
Version |
1.2.722.0 | |
Driver for |
Windows 2000 (5.0) 64 bit Windows XP (5.1) 64 bit Windows Server 2003 (5.2) 64 bit Windows Vista (6.0) 64 bit Windows 7 (6.1) 64 bit Windows 8 (6.2) 64 bit Windows 8.1 (6.3) 64 bit Windows 10 (10.0) 64 bit |
Download |
| Name | Mylan N.V. |
| Industry | Pharmaceuticals |
| Key people | Heather Bresch, CEO |
| Operating income | decrease (2018) |
| Number of employees | ~35,000 (December 2018) |
Mylan N.V. was a global generic and specialty pharmaceuticals company domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US. In 2007, the company acquired a controlling interest in India-based Matrix Laboratories Limited, a top producer of active pharmaceutical ingredients (APIs) for generic drugs, and the generics business of Germany-based Merck KGaA. Through these acquisitions, the company grew from the third-largest generic and pharmaceuticals company in the United States to the second-largest generic and specialty pharmaceuticals company in the world. The company develops and produces medicines for a wide range of medical disciplines, including oncology, anaphylaxis, antiretrovirals, cardiovascular, respiratory, dermatology, immunology, anesthesia and pain management, infectious disease, gastroenterology, diabetology/endocrinology, and women's healthcare. In July 2019, the company and Pfizer announced that Pfizer would spin off and merge its off-patent medicine division, Upjohn, with Mylan. The merged company now operates under the name of Viatris.